Greg Mirigian

Greg Mirigian's Title

Greg Mirigian currently serves as the Vice President of Research and Development (R&D) at JenaValve. In this critical role, he oversees the innovation and development of cutting-edge medical device technologies, particularly in the realm of transcatheter heart valve systems. His leadership and technical acumen drive the company's mission to advance cardiovascular health through innovative solutions.

Greg Mirigian's Company

Since joining JenaValve in 2016, Greg Mirigian has been a key player in the company's strategic and technological advancements. JenaValve specializes in developing transcatheter aortic valve replacement (TAVR) systems designed to improve patient outcomes in treating severe aortic stenosis and aortic regurgitation. Greg's contributions have been pivotal in the company's growth and its future technology pipeline, cementing JenaValve's position as a leader in the cardiovascular market.

Greg Mirigian's Education and Expertise

Greg Mirigian graduated from San Jose State University with a Bachelor's Degree in Mechanical Engineering and a minor in Business. His robust educational background laid the foundation for a distinguished career in medical device technology. With over 25 years of experience, Greg has honed his expertise in neurovascular, peripheral vascular, and cardiovascular markets, making significant contributions to product development and commercialization.

Greg Mirigian's Achievements

An innovator at heart, Greg Mirigian holds over 30 issued patents across various medical device fields. His notable achievements include the successful development of JenaValve's transcatheter heart valve system and other future technologies. Additionally, Greg established a successful R&D consulting firm, assisting clients from start-ups to Fortune 500 corporations. His tenure at Boston Scientific saw the development of multiple commercial products, including catheters, guidewires, and embolic coils, underscoring his ability to bring novel medical devices to market.

Greg Mirigian's Background

Before his current role at JenaValve, Greg Mirigian served as the Chief Technology Officer for INCUMEDx, an R&D-focused medical device incubator. Here, he furthered the development of neurovascular and cardiovascular devices and surgical implants. He also held several leadership roles at Boston Scientific Neurovascular and Boston Scientific Japan over 16 years, contributing to the advancement of various medical technologies. His background in mechanical engineering and business, combined with his extensive industry experience, positions him as a thought leader and innovator in the medical device sector.